Denosumab Monoclonal Antibody from United States
Denosumab is a fully human monoclonal antibody that inhibits RANKL and is used to treat osteoporosis and bone metastases. This bulk, unmixed product is not put up in measured doses or retail packaging, qualifying it for tariff item 3002.13.00.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the product is imported as a pure, unmixed substance without any added excipients
• Keep documentation of the biotechnological manufacturing process for CBSA inspection
• Verify whether the product requires a Drug Identification Number (DIN) or is exempt as a bulk ingredient